Chiemi Hirose

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study

Hironori Fujii, Nobuhisa Matsuhashi, Mika Kitahora et al. · The Oncologist · 2019 · 44 citations · Full text

Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non‐small‐cell lung cancer

Hideki Hayashi, Yutaro Kita, Hirotoshi Iihara et al. · Biomedical Chromatography · 2015 · 38 citations

Engineering, Pathology, Nsclc Treatment +29

Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy

Chiemi Hirose, Hironori Fujii, Hirotoshi Iihara et al. · Supportive Care in Cancer · 2020 · 31 citations · Full text

Quality Of Life, Family Medicine, Life Assessment +28

Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy

Hironori Fujii, Chiemi Hirose, Masashi Ishihara et al. · Anticancer Research · 2018 · 28 citations · Full text

Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancer

Hideki Hayashi, Hirotoshi Iihara, Chiemi Hirose et al. · Lung Cancer · 2019 · 27 citations

Side Effect Profile, Medicine, Pharmacology +7